The Fourth Circuit Court of Appeals upheld West Virginia's law banning medication abortion, enabling states to restrict access to FDA-approved medications. This decision marks a significant shift, with the court being the first to sanction a ban on the most common form of abortion care in the U.S. It challenges the FDA's regulatory authority. Medication abortion constitutes 63 percent of abortions in the U.S. as of 2023, and this ruling could encourage further legal actions against abortion rights in other states.
The Fourth Circuit Court of Appeals upheld West Virginia's law banning FDA-approved medication abortion, marking the first federal court to sanction such a ban and undermining the FDA's regulatory authority.
Medication abortion, consisting of mifepristone and misoprostol, comprised 63 percent of all U.S. abortions as of 2023, highlighting its role in reproductive healthcare.
Collection
[
|
...
]